Antlia Bioscience, Inc

We are comprised of a dedicated group of scientists focused on developing next-generation therapeutics to treat chronic diseases. We use PASylation® a proprietary and powerful chemistry platform to design novel long-acting peptides with fine-tuned pharmacologic and pharmacokinetic properties to create promising therapeutics for multiple chronic diseases. At Antlia Bioscience, we are driven to make a profound difference in the treatment of cardiovascular and pulmonary diseases. Our work is supported by world-class advisors and collaborators who are all aligned with our vision to bring life-changing therapies to the market.